Fresh Tracks Therapeutics, Inc. (FRTX)の価格はいくらですか

Fresh Tracks Therapeutics, Inc. (FRTX)の価格は$0.94です

Fresh Tracks Therapeutics, Inc. (FRTX)の時価総額は何ですか

Fresh Tracks Therapeutics, Inc. (FRTX)の時価総額は$2.73Mです

Fresh Tracks Therapeutics, Inc.（FRTX）株式分割

Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.

年	株式分割	分割比率	累積分割比率
2022-07-05	1:45	x0.022222222222222	x0.00031746031746032
2019-09-03	1:7	x0.14285714285714	x0.014285714285714
2016-05-27	1:10	x0.1	x0.1

年

株式分割

分割比率

累積分割比率

2022-07-05

1:45

x0.022222222222222

x0.00031746031746032

2019-09-03

1:7

x0.14285714285714

x0.014285714285714

2016-05-27

1:10

x0.1

企業	株式分割の回数	累積分割比率	国
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

企業

株式分割の回数

累積分割比率

国